Anti-rituximab antibodies demonstrate neutralising capacity, associate with lower circulating drug levels and earlier relapse in lupus.
Sign Up to like & getrecommendations! Published in 2022 at "Rheumatology"
DOI: 10.1093/rheumatology/keac608
Abstract: OBJECTIVES High rates of anti-drug antibodies (ADA) to rituximab have been demonstrated in patients undergoing treatment for systemic lupus erythematosus (SLE). However, little is known with regards to their long-term dynamics, impact on drug kinetics… read more here.
Keywords: neutralising capacity; circulating drug; treatment; drug ... See more keywords
Humoral response and neutralising capacity at 6 months post-vaccination against COVID-19 among institutionalised older adults in Argentina
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Immunology"
DOI: 10.3389/fimmu.2022.992370
Abstract: The COVID-19 pandemic has particularly affected older adults residing in nursing homes, resulting in high rates of hospitalisation and death. Here, we evaluated the longitudinal humoral response and neutralising capacity in plasma samples of volunteers… read more here.
Keywords: vaccination; capacity; response neutralising; neutralising capacity ... See more keywords